Overview
Bartonella bacilliformis infection, also known as Carrión's disease or Oroya fever (in its acute phase) and Verruga peruana (in its chronic phase), is a rare bacterial infection caused by the bacterium Bartonella bacilliformis. This infection is spread through the bite of infected sandflies, particularly Lutzomyia verrucarum, and is found almost exclusively in certain mountainous regions of South America, especially Peru, Ecuador, and Colombia. The disease has two distinct stages. The first stage, called Oroya fever or the acute phase, is a serious illness where the bacteria invade red blood cells and destroy them, causing severe anemia. This can be life-threatening if not treated quickly. Symptoms include high fever, chills, headache, muscle pain, and extreme fatigue. The second stage, called Verruga peruana or the chronic phase, causes distinctive reddish-purple skin growths or wart-like bumps that can appear weeks to months after the initial infection. These skin lesions are usually not life-threatening but can be uncomfortable and disfiguring. Fortunately, Bartonella bacilliformis infection responds well to antibiotic treatment. The acute phase is typically treated with antibiotics such as ciprofloxacin or chloramphenicol, while the chronic skin phase is often treated with rifampicin or azithromycin. With prompt diagnosis and proper antibiotic therapy, most people recover fully. Without treatment, the acute phase can be fatal in a significant number of cases.
Key symptoms:
High feverSevere anemia (low red blood cell count causing extreme tiredness and paleness)Chills and shakingHeadacheMuscle and joint painNausea and vomitingYellowing of the skin or eyes (jaundice)Enlarged lymph nodesReddish-purple wart-like skin bumps or nodules (in the chronic phase)Skin lesions that may bleed easilyExtreme fatigue and weaknessRapid heart rateDizziness or fainting
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
3 eventsJanssen Research & Development, LLC — PHASE3
Janssen Research & Development, LLC — PHASE2
Eli Lilly and Company — PHASE3
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
3 availableEpclusa
EPCLUSA is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection with compensated cirrhosis
MAVYRET
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with c…
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A).
Remicade
reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy
Clinical Trials
View all trials with filters →No actively recruiting trials found for Bartonella bacilliformis infection at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Bartonella bacilliformis infection.
Treatment Centers
8 centersChildren's Hospital of Philadelphia
📍 Philadelphia, Pennsylvania
👤 Study Director
👤 Richard Neibeger, MD
Cedars Sinai Medical Center
📍 Los Angeles, California
👤 Janssen Research & Development, LLC Clinical Trial
Columbia University Medical Center
📍 New York, New York
👤 Janssen Research & Development, LLC Clinical Trial
👤 Anthony A. Amato, MD
Emory University
📍 Atlanta, Georgia
Connecticut Children's Medical Center
📍 Hartford, Connecticut
University of Colorado
📍 Aurora, Colorado
Riley Hospital for Children
📍 Indianapolis, Indiana
University of California San Francisco
📍 San Francisco, California
Financial Resources
2 resourcesTravel Grants
No travel grants are currently matched to Bartonella bacilliformis infection.
Community
No community posts yet. Be the first to share your experience with Bartonella bacilliformis infection.
Start the conversation →Latest news about Bartonella bacilliformis infection
Disease timeline:
New trial: A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Phase PHASE3 trial recruiting. Mirikizumab
New trial: A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Seve
Phase PHASE2 trial recruiting. Guselkumab
New trial: A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Phase PHASE3 trial recruiting. Guselkumab
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which phase of Bartonella bacilliformis infection do I have, and what does that mean for my treatment?,What antibiotic will I be prescribed, and how long do I need to take it?,Do I need a blood transfusion because of anemia, and how will you monitor my blood counts?,What warning signs should prompt me to go to the emergency room?,How will we know the treatment has worked, and what follow-up tests are needed?,Am I at risk of developing the chronic skin phase (Verruga peruana) after the acute illness?,How can I prevent reinfection if I live in or plan to return to an endemic area?
Common questions about Bartonella bacilliformis infection
What is Bartonella bacilliformis infection?
Bartonella bacilliformis infection, also known as Carrión's disease or Oroya fever (in its acute phase) and Verruga peruana (in its chronic phase), is a rare bacterial infection caused by the bacterium Bartonella bacilliformis. This infection is spread through the bite of infected sandflies, particularly Lutzomyia verrucarum, and is found almost exclusively in certain mountainous regions of South America, especially Peru, Ecuador, and Colombia. The disease has two distinct stages. The first stage, called Oroya fever or the acute phase, is a serious illness where the bacteria invade red blood
How is Bartonella bacilliformis infection inherited?
Bartonella bacilliformis infection follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
What treatment and support options exist for Bartonella bacilliformis infection?
2 patient support programs are currently tracked on UniteRare for Bartonella bacilliformis infection. See the treatments and support programs sections for copay assistance, eligibility, and contact details.